Last edition
News about "cancer therapies "
US FDA Appoints Richard Pazdur as Director of CDER
Pazdur is a 26-year veteran of the FDA and the Founding Director of its Oncology Center of Excellence (CoE). A regulatory innovator, he developed an integrated approach for cross-centre coordination of oncology product review to expedite the development of novel cancer therapies.
Cancer Therapies | 13/11/2025 | By Dineshwori
NAYA Therapeutics, a US-based clinical-stage biopharmaceutical company developing next-generation cancer therapies, has entered into a research and manufacturing partnership with China’s Alpha Nuclide, a radiopharmaceutical solutions company leading global efforts in Astatine-211 (211At) supply and CDMO services.
Cancer Therapies | 17/10/2025 | By Dineshwori | 158
FDA Grants BTD to Raludotatug Deruxtecan for Platinum-Resistant Ovarian Cancer
This is the first BTD granted for Raludotatug Deruxtecan, the second for the Daiichi Sankyo-Merck partnership and the 15th across Daiichi Sankyo’s oncology portfolio, marking a significant milestone in the companies’ joint efforts to develop innovative cancer therapies.
Cancer Therapies | 16/09/2025 | By Dineshwori | 125
Johnson and Johnson Commits USD 2 Billion to Expand US Manufacturing Amid Tariff Pressures
Johnson and Johnson has announced it will invest USD 2 billion in expanding its US manufacturing capacity over the next decade, responding to escalating concerns over trade and potential drug import tariffs.
Cancer Therapies | 22/08/2025 | By Darshana | 107
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy